Search
Nicotinyl alcohol
go.drugbank.com/drugs/DB04145ExperimentalA direct-acting peripheral vasodilator that causes flushing and may decrease blood pressure. It is used in vasospasm and threatened gangrene. [PubChem]
(R)-Rolipram
go.drugbank.com/drugs/DB04149InvestigationalThe (R)-enantiomer of rolipram, it is a phosphodiesterase inhibitor with antidepressant properties.
Digitoxigenin
go.drugbank.com/drugs/DB04177ExperimentalDigitoxigenin is a cardenolide which is the aglycon of digitoxin.
Homocysteine
go.drugbank.com/drugs/DB04422InvestigationalHomocysteine is a thiol-containing amino acid formed by a demethylation of methionine.
Afimoxifene
go.drugbank.com/drugs/DB04468InvestigationalAfimoxifene (4-Hydroxytamoxifen, trade name TamoGel) is a new estrogen inhibitor under investigation for a variety of estrogen-dependent conditions, including cyclic breast pain and gynecomastia.
Categories: Estrogen Receptor Modulators, Selective Estrogen Receptor ModulatorsChlorophyll B
go.drugbank.com/drugs/DB04506ExperimentalA light, silvery, metallic element. It has the atomic symbol Mg, atomic number 12, and atomic weight 24.31. … It is a component of both intra- and extracellular fluids and is excreted in the urine and feces.
Cytidine-5'-Diphosphate
go.drugbank.com/drugs/DB04555InvestigationalA cytosine nucleotide containing two phosphate groups esterified to the sugar moiety. Synonyms: CRPP; cytidine pyrophosphate. [PubChem]
Imazaquin
go.drugbank.com/drugs/DB04582ExperimentalCategories: Compounds used in a research, industrial, or household setting2,5-di-tert-butylhydroquinone
go.drugbank.com/drugs/DB04638ExperimentalCategories: Compounds used in a research, industrial, or household settingOcriplasmin
go.drugbank.com/drugs/DB08888ApprovedWithdrawnOcriplasmin is a recombinant truncated form of human plasmin with a molecular weight of 27.2 kDa produced by recombinant DNA technology in a Pichia pastoris expression system. … Ocriplasmin is a protein made up of 249 amino acids and has two peptide chains. Agent for pharmacologic vitreolysis; thrombolytic agent. FDA approved in October 17, 2012.